Citizen in a RepublicNH Bill Briefing
← All bills

HB 1734 · 2026 · House · Health, Human Services and Elderly Affairs Committee

Study committee on experimental treatment centers

AI-generated

(New Title) establishing a committee to study the feasibility of establishing experimental treatment centers in New Hampshire and the oversight thereof.

Establishes a committee to study the feasibility and oversight of establishing experimental treatment centers in New Hampshire.AI-generated

Status

Recommended for passage but never voted; died at adjournment · May 8, 2026
  1. Introduced
  2. House
  3. Senate
  4. Governor
  5. Law

Analysis

This bill permits the establishment of experimental treatment centers. The centers would be authorized by the department of health and human services to provide treatment involving an investigational drug, biologic, or device that has successfully completed phase one of a clinical trial, but is not yet FDA-approved for general use and either remains under investigation in a clinical trial or has a demonstrated safety record from a qualified medical institution.

From the bill's official ANALYSIS section.

Official record

gc.nh.gov · the authoritative source

Sponsors

Rep. Steven KesselringRPrime
  • Rep. Brian ColeRVice Chair· Housing
  • Rep. Lisa MazurRVice Chair· Health, Human Services and Elderly Affairs
  • Rep. Dan McGuireRVice Chair· Finance
  • Rep. JD BernardyRClerk· Science, Technology and Energy
  • Rep. Jason OsborneRMajority Leader
  • Sen. Keith MurphyRDeputy President Pro Tempore
  • Sen. Victoria SullivanRVice Chair· Education
  • Sen. Daniel InnisRChair, Majority Policy Conference

Also: Rep. Yury PolozovR, Rep. Jay MarkellR, Rep. Jim KofaltR, Rep. Julie MilesR, Sen. Tim McGoughR

Public testimony

21 signed in online · 6 wrote testimony

81% support14% oppose5% neutral

In their wordsVerbatim, exactly as submitted

My name is Dr. Kris Barnes. I am the CEO and founder of Lento Bio, a preclinical-stage biotechnology company developing treatments for age-related diseases.
Kris Barnes, Syracuse · Lento Biosupports
My name is Andy DeMeo, and I am writing in support of HB 1734-FN. I run a New Hampshire–based media project focused on optimism and progress, telling stories about people working constructively on hard problems.
Andrew DeMeo, Madisonsupports
Dear Chair and Members of the House Health, Human Services, and Elderly Affairs Committee, My name is Dr. Ronald A. Primas, and I am a board-certified internist and preventive medicine physician with a clinical and professional focus on longevity, metabolic health, and innovation in age-related and chronic disease care.
Ronald Primas, MD, New Yorksupports
This sounds like a very scary experiment that will harm the most vulnerable among us. Seems like the intent could be adjunct to already functioning healthcare research centers, not to mention the cost.
Carlene Ferrier, Concord, NHopposes
Allows experimental treatment centers. HB 1734 authorizes the creation of experimental treatment centers permitted to administer non-FDA-approved drugs, biologics, and medical devices that have completed only Phase I clinical trials, while explicitly exempting such centers from insurance mandates, network adequacy requirements, and many traditional licensing protections.
Georgina Lambert, Belmontopposes
As a practicing family physician I oppose HB 1734 for several reasons: 1. More information needed: HB 701 was just signed into law last year and we need to better understand how it is working for patients with terminal illnesses before expanding access to experimental drugs to chronic medical conditions.
P. Travis Harker MD, Manchesteropposes

Verbatim excerpts of submitted testimony, quoted from the testimony tool.

Read the testimony · as of Aug 12, 2026

Hearings

  • 2026-01-289:00 amHouse Health, Human Services and Elderly AffairsGP 158Public hearing
  • 2026-02-112:30 pmHouse Health, Human Services and Elderly AffairsGP 158Public hearing
  • 2026-04-019:00 amSenate Health and Human ServicesSH 100Public hearing

Legislative history

  1. Jan 7, 2026HouseIntroduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 33
  2. Jan 28, 2026HousePublic Hearing: 01/28/2026 09:00 am GP 158
  3. Feb 11, 2026HouseExecutive Session: 02/11/2026 02:30 pm GP 158
  4. Feb 11, 2026HouseMajority : Ought to Pass with Amendment # 2026-0666h 02/11/2026 (Vote 10-8; RC) HC 10 P. 52
  5. Feb 25, 2026HouseMinority : Inexpedient to Legislate
  6. Mar 11, 2026HouseAmendment # 2026-0666h: AA DV 181-151 03/11/2026 HJ 7 P. 202
  7. Mar 11, 2026HouseOught to Pass with Amendment 2026-0666h: MA DV 182-152 03/11/2026 HJ 7 P. 203
  8. Mar 12, 2026SenIntroduced 03/12/2026 and Referred to Health and Human Services; SJ 7
  9. Apr 1, 2026SenHearing: 04/01/2026, Room 100, SH, 09:15 am; SC 12
  10. May 14, 2026Sen: Ought to Pass with Amendment # 2026-1864s, 05/14/2026; Vote 5-0; CC; SC 18
  11. May 14, 2026SenCommittee Amendment # 2026-1864s, AA, VV; 05/14/2026; SJ 12
  12. May 14, 2026SenOught to Pass with Amendment # 2026-1864s, MA, VV; OT3rdg; 05/14/2026; SJ 12
  13. May 14, 2026HouseHouse Non-Concurs with Senate Amendment 2026-1864s and Requests CofC (Rep. W. MacDonald): MA VV 05/14/2026 HJ 13 P. 151
  14. May 14, 2026HouseSpeaker Appoints: Reps. W. MacDonald, Drew, Markell, Milz 05/14/2026 HJ 13 P. 152
  15. May 21, 2026SenSen. Rochefort Refused to Accede to House Request for Committee of Conference, MA, VV; 05/21/2026; SJ 13

Coverage

No reporting linked yet.

Documents (PDF)

Bill text & amendments link direct to gc.nh.gov; committee reports stream from the state record.